Avricore Health Inc Share Price Toronto S.E.
Equities
APH
CA92143R2046
Pharmaceuticals
Sales 2022 | 1.77M 1.29M 108M | Sales 2023 | 3.49M 2.55M 213M | Capitalization | 16.94M 12.39M 1.03B |
---|---|---|---|---|---|
Net income 2022 | - 0 0 | Net income 2023 | - 0 0 | EV / Sales 2022 | 17.3 x |
Net cash position 2022 | 591K 432K 36.07M | Net cash position 2023 | 247K 180K 15.06M | EV / Sales 2023 | 4.79 x |
P/E ratio 2022 |
-37.7
x | P/E ratio 2023 |
-24.1
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 90.31% |
Managers | Title | Age | Since |
---|---|---|---|
Hector Bremner
CEO | Chief Executive Officer | - | 01/19/01 |
Kiki Smith
DFI | Director of Finance/CFO | - | 06/19/06 |
Rodger Seccombe
CTO | Chief Tech/Sci/R&D Officer | - | 08/20/08 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Hall
CHM | Chairman | 71 | 20/16/20 |
Robert Sindelar
BRD | Director/Board Member | 71 | 27/18/27 |
Christine Hrudka
BRD | Director/Board Member | - | 21/23/21 |
1st Jan change | Capi. | |
---|---|---|
+29.98% | 684B | |
+30.34% | 568B | |
-3.52% | 361B | |
+18.59% | 329B | |
+4.07% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+7.09% | 166B |